Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Abstract Clusterin (CLU) is a stress‐activated molecular chaperone that confers treatment resistance to taxanes when highly expressed. While CLU inhibition potentiates activity of taxanes and other anti‐cancer therapies in preclinical models, progression to treatment‐resistant disease still occurs i...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Springer Nature
2016-05-01
|
| Sraith: | EMBO Molecular Medicine |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.15252/emmm.201506059 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|